Dr. Klaus-Michael Weltring is a molecular biologist by training with a PhD and a Habilitation degree from the University of Muenster. Since 2001 he is the managing director of Bioanalytik-Muenster responsible for the development of the Muenster region into a leading nanobioanalytic location at the European level.
He has set-up a local network of researchers from different disciplines and SMEs and organizes the marketing of the region at international events and fairs. Between 2003 and 2008 he was the deputycoordinator of the Nano2Life Network of Excellence and leader of the “ELSA” Board in this network. In this project he organized two expert workshops on ELSA aspects of nanobiotechnology. Until recently he co-managed the Nanomedicine Round Table and the EuroNanoBio project (FP7 CSA projects). In addition he is a member of the Executive Board of the ETP Nanomedicine leading the ELSA Advisory Group of this platform. In summer 2010 he co-organized the event “Nanomedicine in Europe: present and for the future” at the European Parliament.